SAMDaily.us | SNOTE | 65 | Justification and Approval for Sole Source TPOXX Requirement

SAMDAILY.US - ISSUE OF MAY 19, 2022 SAM #7475
SPECIAL NOTICE

65 -- Justification and Approval for Sole Source TPOXX Requirement

Notice Date: 5/17/2022 10:24:43 AM
Notice Type: Justification
NAICS: 325412 — Pharmaceutical Preparation Manufacturing
Contracting Office: W6QK ACC-APG ABERDEEN PROVING GROU MD 21010-5424 USA
ZIP Code: 21010-5424
Solicitation Number: JA-21-Edg-645
Archive Date: 06/16/2022
Point of Contact: Scott Hoffman, Phone: 301.619.8148, Richard Totten, Phone: 3016192446
E-Mail Address: scott.i.hoffman2.civ@army.mil, richard.w.totten2.civ@army.mil
(scott.i.hoffman2.civ@army.mil, richard.w.totten2.civ@army.mil)
Award Number: W911SR22C0032
Award Date: 05/12/2022
Description: The purpose of this sole source award to Siga Tecnologies Inc., is to replenish existing National Stock Pile quantities of TPOXX, an oral Small Pox Treatment capsule, approved by the US FDA in 2018.
Web Link: SAM.gov Permalink
(https://sam.gov/opp/3584ae076760481caab8c2a40fa7ce37/view)
Place of Performance: Address: New York, NY 10065, USA; Zip Code: 10065; Country: USA
Record: SN06329065-F 20220519/220517230100 (samdaily.us)
Source: SAM.gov Link to This Notice
(may not be valid after Archive Date)

| FSG Index | This Issue's Index | Today's SAM Daily Index Page |